I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Selle, Frédéric
93
results:
Search for persons
X
Format
Online (93)
Mediatypes
Articles (Online) (26)
OpenAccess-fulltext (67)
Languages
english (56)
french (24)
Sorted by: Relevance
Sorted by: Year
?
1
Bevacizumab, olaparib, and durvalumab in patients with rela..:
Freyer, Gilles
;
Floquet, Anne
;
Tredan, Olivier
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
Neoadjuvant and adjuvant pembrolizumab in advanced high-gra..:
Ray-Coquard, Isabelle L.
;
Savoye, Aude-Marie
;
Schiffler, Camille
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
3
Author Correction: Bevacizumab, olaparib, and durvalumab in..:
Freyer, Gilles
;
Floquet, Anne
;
Tredan, Olivier
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
A phase II, multicenter, open-label study of abemaciclib an..:
Ottenbourgs, Tine
;
van Gorp, Toon
;
Kridelka, Frédéric
...
International Journal of Gynecologic Cancer. 34 (2024) 4 - p. 627-630 , 2024
Link:
https://doi.org/10.1136/..
?
5
The association of histopathologic features after neoadjuva..:
Mhawech-Fauceglia, Paulette
;
McCarthy, Denis
;
Tonooka, Akiko
...
Gynecologic Oncology. 186 (2024) - p. 17-25 , 2024
Link:
https://doi.org/10.1016/..
?
6
Impact of surgery and chemotherapy in ovarian sex cord-stro..:
Hanvic, Brunhilde
;
Lecuru, Fabrice
;
Vanacker, Hélène
...
Gynecologic Oncology. 174 (2023) - p. 190-199 , 2023
Link:
https://doi.org/10.1016/..
?
7
Gestion pratique des inhibiteurs de PARP : Un consensus nat..:
Selle, Frédéric
;
Boffa, Jean-Jacques
;
Etienne, Gabriel
...
Bulletin du Cancer. 109 (2022) 12 - p. 1245-1261 , 2022
Link:
https://doi.org/10.1016/..
?
8
Efficacy of niraparib by time of surgery and postoperative ..:
O'Cearbhaill, Roisin E.
;
Pérez-Fidalgo, Jose-Alejandro
;
Monk, Bradley J.
...
Gynecologic Oncology. 166 (2022) 1 - p. 36-43 , 2022
Link:
https://doi.org/10.1016/..
?
9
Low probability of disease cure in advanced ovarian carcino..:
You, Benoit
;
Van Wagensveld, Lilian
;
Tod, Michel
...
British Journal of Cancer. 127 (2022) 1 - p. 79-83 , 2022
Link:
https://doi.org/10.1038/..
?
10
Phase II study of the safety and efficacy of the anti-PD-1 ..:
O'Malley, David M.
;
Oaknin, Ana
;
Monk, Bradley J.
...
Gynecologic Oncology. 163 (2021) 2 - p. 274-280 , 2021
Link:
https://doi.org/10.1016/..
?
11
Chronic fatigue, quality of life and long-term side-effects..:
Gernier, François
;
Ahmed-Lecheheb, Djihane
;
Pautier, Patricia
...
BMC Cancer. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
12
Patient-centred outcomes and effect of disease progression ..:
Friedlander, Michael
;
Moore, Kathleen N
;
Colombo, Nicoletta
...
The Lancet Oncology. 22 (2021) 5 - p. 632-642 , 2021
Link:
https://doi.org/10.1016/..
?
13
Efficacy of niraparib by timing of surgery and residual dis..:
O'Cearbhaill, Roisin
;
Pérez-Fidalgo, Jose Alejandro
;
Monk, Bradley
...
Gynecologic Oncology. 162 (2021) - p. S65 , 2021
Link:
https://doi.org/10.1016/..
?
14
Real-World Experience of Bevacizumab as First-Line Treatmen..:
Berton, Dominique
;
Floquet, Anne
;
Lescaut, Willy
...
Frontiers in Pharmacology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
15
Fertility preservation, contraception and menopause hormone..:
Rousset-Jablonski, Christine
;
Selle, Fréderic
;
Adda-Herzog, Elodie
...
European Journal of Cancer. 116 (2019) - p. 35-44 , 2019
Link:
https://doi.org/10.1016/..
1-15